Occupe actuellement un poste chez AVROBIO Inc
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | AVROBIO Inc | 1 février 2016 - |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-03-15 | 2024-03-15 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
10 411
-1.3%
40,62422 895 USD |
10 411 -1.3% | 40,62 | 422 895 USD | |
2024-03-15 | 2024-03-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
7 292
-0.9%
39,73289 711 USD |
7 292 -0.9% | 39,73 | 289 711 USD | |
2024-03-15 | 2024-03-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
781
-0.0%
41,5132 419 USD |
781 -0.0% | 41,51 | 32 419 USD | |
2024-03-15 | 2024-03-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
10 846
-0.2%
40,66440 998 USD |
10 846 -0.2% | 40,66 | 440 998 USD | |
2024-03-15 | 2024-03-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
34 473
-0.7%
39,731 369 612 USD |
34 473 -0.7% | 39,73 | 1 369 612 USD | |
2024-03-13 | 2024-03-13 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
1 386
-0.2%
42,8459 376 USD |
1 386 -0.2% | 42,84 | 59 376 USD | |
2024-03-13 | 2024-03-13 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
22 779
-2.7%
42,19961 046 USD |
22 779 -2.7% | 42,19 | 961 046 USD | |
2024-03-13 | 2024-03-13 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
6 686
-0.1%
42,84286 428 USD |
6 686 -0.1% | 42,84 | 286 428 USD | |
2024-03-13 | 2024-03-13 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
108 404
-2.3%
42,194 573 565 USD |
108 404 -2.3% | 42,19 | 4 573 565 USD | |
2024-03-13 | 2024-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
1 819
-0.2%
42,5277 344 USD |
1 819 -0.2% | 42,52 | 77 344 USD | |
2024-03-13 | 2024-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
26 452
-3.0%
41,941 109 397 USD |
26 452 -3.0% | 41,94 | 1 109 397 USD | |
2024-03-13 | 2024-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
8 581
-0.2%
42,52364 864 USD |
8 581 -0.2% | 42,52 | 364 864 USD | |
2024-03-13 | 2024-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
126 066
-2.6%
41,945 287 208 USD |
126 066 -2.6% | 41,94 | 5 287 208 USD | |
2024-03-13 | 2024-03-11 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
1 045
-0.1%
43,4245 374 USD |
1 045 -0.1% | 43,42 | 45 374 USD | |
2024-03-13 | 2024-03-11 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
7 837
-0.9%
42,77335 188 USD |
7 837 -0.9% | 42,77 | 335 188 USD | |
2024-03-13 | 2024-03-11 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
5 122
-0.1%
43,42222 397 USD |
5 122 -0.1% | 43,42 | 222 397 USD | |
2024-03-13 | 2024-03-11 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
37 180
-0.7%
42,771 590 189 USD |
37 180 -0.7% | 42,77 | 1 590 189 USD | |
2023-01-13 | 2023-01-12 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
21 592
-2.4%
30,29654 022 USD |
21 592 -2.4% | 30,29 | 654 022 USD | |
2023-01-13 | 2023-01-12 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
77 128
-1.5%
30,292 336 207 USD |
77 128 -1.5% | 30,29 | 2 336 207 USD | |
2023-01-13 | 2023-01-11 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
6 071
-0.7%
29,96181 887 USD |
6 071 -0.7% | 29,96 | 181 887 USD | |
2023-01-13 | 2023-01-11 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
21 683
-0.4%
29,96649 623 USD |
21 683 -0.4% | 29,96 | 649 623 USD | |
2022-12-16 | 2022-12-15 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
717
-0.1%
30,0021 510 USD |
717 -0.1% | 30,00 | 21 510 USD | |
2022-12-16 | 2022-12-15 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
2 561
-0.1%
30,0076 830 USD |
2 561 -0.1% | 30,00 | 76 830 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
3 733
-0.4%
34,02126 997 USD |
3 733 -0.4% | 34,02 | 126 997 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
3 919
-0.4%
33,34130 659 USD |
3 919 -0.4% | 33,34 | 130 659 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
15 324
-1.6%
32,33495 425 USD |
15 324 -1.6% | 32,33 | 495 425 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
28 329
-2.9%
31,44890 664 USD |
28 329 -2.9% | 31,44 | 890 664 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
31 584
-3.2%
30,28956 364 USD |
31 584 -3.2% | 30,28 | 956 364 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
13 335
-0.3%
34,02453 657 USD |
13 335 -0.3% | 34,02 | 453 657 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
13 997
-0.3%
33,34466 660 USD |
13 997 -0.3% | 33,34 | 466 660 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
54 737
-1.1%
32,331 769 647 USD |
54 737 -1.1% | 32,33 | 1 769 647 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
101 189
-1.9%
31,443 181 382 USD |
101 189 -1.9% | 31,44 | 3 181 382 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
112 819
-2.1%
30,283 416 159 USD |
112 819 -2.1% | 30,28 | 3 416 159 USD | |
2022-11-04 | 2022-11-03 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
21 085
-2.1%
30,00632 550 USD |
21 085 -2.1% | 30,00 | 632 550 USD | |
2022-11-04 | 2022-11-03 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
75 312
-1.4%
30,002 259 360 USD |
75 312 -1.4% | 30,00 | 2 259 360 USD | |
2022-11-04 | 2022-11-02 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
27 038
-2.6%
30,02811 681 USD |
27 038 -2.6% | 30,02 | 811 681 USD | |
2022-11-04 | 2022-11-02 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
96 581
-1.7%
30,022 899 362 USD |
96 581 -1.7% | 30,02 | 2 899 362 USD | |
2022-11-01 | 2022-11-01 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
1 044
-0.1%
31,0832 448 USD |
1 044 -0.1% | 31,08 | 32 448 USD | |
2022-11-01 | 2022-11-01 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
3 727
-0.1%
31,08115 835 USD |
3 727 -0.1% | 31,08 | 115 835 USD | |
2022-11-01 | 2022-11-01 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
15 804
-1.5%
30,57483 128 USD |
15 804 -1.5% | 30,57 | 483 128 USD | |
2022-11-01 | 2022-11-01 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
56 455
-1.0%
30,571 725 829 USD |
56 455 -1.0% | 30,57 | 1 725 829 USD | |
2022-11-01 | 2022-10-31 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
26 383
-2.4%
30,23797 558 USD |
26 383 -2.4% | 30,23 | 797 558 USD | |
2022-11-01 | 2022-10-31 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
94 239
-1.7%
30,232 848 845 USD |
94 239 -1.7% | 30,23 | 2 848 845 USD | |
2022-11-01 | 2022-10-28 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
19 915
-1.8%
30,00597 450 USD |
19 915 -1.8% | 30,00 | 597 450 USD | |
2022-11-01 | 2022-10-28 |
Kymera Therapeutics Inc
(KYMR)
|
VP Vente planifiée |
71 135
-1.2%
30,002 134 050 USD |
71 135 -1.2% | 30,00 | 2 134 050 USD | |
2022-01-11 | 2022-01-11 |
Vigil Neuroscience Inc
(VIGL)
|
A Achat |
535 000
+12.5%
14,007 490 000 USD |
535 000 +12.5% | 14,00 | 7 490 000 USD | |
2021-08-12 | 2021-08-11 |
Kymera Therapeutics Inc
(KYMR)
|
V Vente |
242 133
-100.0%
61,0014 770 113 USD |
242 133 -100.0% | 61,00 | 14 770 113 USD | |
2021-03-16 | 2021-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
V Vente |
229 350
-100.0%
56,5012 958 275 USD |
229 350 -100.0% | 56,50 | 12 958 275 USD | |
2020-07-01 | 2020-06-29 |
Magenta Therapeutics Inc
(MGTA)
|
A Achat |
1 250 000
+inf%
8,0010 000 000 USD |
1 250 000 +inf% | 8,00 | 10 000 000 USD | |
2019-07-23 | 2019-07-19 |
AVROBIO Inc
(AVRO)
|
A Achat |
810 811
+17.0%
18,5015 000 004 USD |
810 811 +17.0% | 18,50 | 15 000 004 USD | |
2019-03-22 | 2019-03-20 |
Magenta Therapeutics Inc
(MGTA)
|
V Vente |
14 245
-100.0%
17,86254 416 USD |
14 245 -100.0% | 17,86 | 254 416 USD |